vs
Side-by-side financial comparison of Relay Therapeutics, Inc. (RLAY) and TRANSCONTINENTAL REALTY INVESTORS INC (TCI). Click either name above to swap in a different company.
TRANSCONTINENTAL REALTY INVESTORS INC is the larger business by last-quarter revenue ($12.1M vs $7.0M, roughly 1.7× Relay Therapeutics, Inc.).
Relay Therapeutics is a clinical-stage biotechnology company focused on developing precision oncology therapies. It leverages advanced computational modeling of protein dynamics, paired with cutting-edge experimental biology, to design targeted medicines for previously intractable cancer types, serving global oncology care markets and patient populations.
Transcontinental Realty Investors Inc. (TCI) is a U.S.-based real estate investment firm that owns, operates and develops a diversified portfolio of residential, commercial and mixed-use properties across core U.S. regional markets. It pursues long-term value growth via strategic property acquisitions, efficient asset management and tailored leasing solutions for individual and business tenants.
RLAY vs TCI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.0M | $12.1M |
| Net Profit | — | $8.3M |
| Gross Margin | — | — |
| Operating Margin | — | -28.9% |
| Net Margin | — | 68.8% |
| Revenue YoY | — | 2.3% |
| Net Profit YoY | — | 7577.8% |
| EPS (diluted) | — | $0.97 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.0M | $12.1M | ||
| Q3 25 | $0 | $12.8M | ||
| Q2 25 | — | $12.2M | ||
| Q1 25 | $7.7M | $12.0M | ||
| Q4 24 | $0 | $11.8M | ||
| Q3 24 | $0 | $11.6M | ||
| Q2 24 | $0 | $11.8M | ||
| Q1 24 | $10.0M | $11.9M |
| Q4 25 | — | $8.3M | ||
| Q3 25 | $-74.1M | $724.0K | ||
| Q2 25 | — | $169.0K | ||
| Q1 25 | $-77.1M | $4.6M | ||
| Q4 24 | — | $108.0K | ||
| Q3 24 | $-88.1M | $1.7M | ||
| Q2 24 | $-92.2M | $1.5M | ||
| Q1 24 | $-81.4M | $2.5M |
| Q4 25 | — | -28.9% | ||
| Q3 25 | — | -10.9% | ||
| Q2 25 | — | -6.8% | ||
| Q1 25 | -1105.2% | -5.3% | ||
| Q4 24 | — | -14.3% | ||
| Q3 24 | — | -14.4% | ||
| Q2 24 | — | -9.2% | ||
| Q1 24 | -903.0% | -11.2% |
| Q4 25 | — | 68.8% | ||
| Q3 25 | — | 5.6% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | -1003.6% | 38.5% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | — | 14.7% | ||
| Q2 24 | — | 12.7% | ||
| Q1 24 | -813.3% | 21.4% |
| Q4 25 | — | $0.97 | ||
| Q3 25 | $-0.43 | $0.08 | ||
| Q2 25 | — | $0.02 | ||
| Q1 25 | $-0.46 | $0.53 | ||
| Q4 24 | — | $0.01 | ||
| Q3 24 | $-0.63 | $0.20 | ||
| Q2 24 | $-0.69 | $0.17 | ||
| Q1 24 | $-0.62 | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $84.0M | $89.0M |
| Total DebtLower is stronger | — | $210.8M |
| Stockholders' EquityBook value | $567.1M | $846.7M |
| Total Assets | $621.3M | $1.1B |
| Debt / EquityLower = less leverage | — | 0.25× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $84.0M | $89.0M | ||
| Q3 25 | $91.6M | $82.7M | ||
| Q2 25 | — | $73.5M | ||
| Q1 25 | $93.5M | $88.6M | ||
| Q4 24 | $124.3M | $99.7M | ||
| Q3 24 | $152.4M | $131.6M | ||
| Q2 24 | $134.1M | $127.5M | ||
| Q1 24 | $152.9M | $130.8M |
| Q4 25 | — | $210.8M | ||
| Q3 25 | — | $223.5M | ||
| Q2 25 | — | $212.4M | ||
| Q1 25 | — | $198.2M | ||
| Q4 24 | — | $181.9M | ||
| Q3 24 | — | $180.3M | ||
| Q2 24 | — | $177.4M | ||
| Q1 24 | — | $178.3M |
| Q4 25 | $567.1M | $846.7M | ||
| Q3 25 | $607.7M | $838.4M | ||
| Q2 25 | — | $837.7M | ||
| Q1 25 | $721.1M | $837.3M | ||
| Q4 24 | $777.8M | $832.3M | ||
| Q3 24 | $838.9M | $832.2M | ||
| Q2 24 | $681.7M | $830.4M | ||
| Q1 24 | $745.8M | $828.9M |
| Q4 25 | $621.3M | $1.1B | ||
| Q3 25 | $670.0M | $1.1B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | $799.4M | $1.1B | ||
| Q4 24 | $871.3M | $1.1B | ||
| Q3 24 | $930.1M | $1.1B | ||
| Q2 24 | $772.5M | $1.0B | ||
| Q1 24 | $841.4M | $1.0B |
| Q4 25 | — | 0.25× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.25× | ||
| Q1 25 | — | 0.24× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | — | 0.22× | ||
| Q2 24 | — | 0.21× | ||
| Q1 24 | — | 0.22× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-235.5M | $-2.9M |
| Free Cash FlowOCF − Capex | $-235.9M | — |
| FCF MarginFCF / Revenue | -3370.0% | — |
| Capex IntensityCapex / Revenue | 5.9% | — |
| Cash ConversionOCF / Net Profit | — | -0.35× |
| TTM Free Cash FlowTrailing 4 quarters | $-622.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-235.5M | $-2.9M | ||
| Q3 25 | $-62.1M | $8.2M | ||
| Q2 25 | — | $-2.9M | ||
| Q1 25 | $-73.2M | $-7.4M | ||
| Q4 24 | $-249.1M | $1.3M | ||
| Q3 24 | $-75.1M | $13.7M | ||
| Q2 24 | $-65.8M | $-511.0K | ||
| Q1 24 | $-50.3M | $3.9M |
| Q4 25 | $-235.9M | — | ||
| Q3 25 | $-62.1M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-73.6M | — | ||
| Q4 24 | $-251.1M | — | ||
| Q3 24 | $-75.3M | — | ||
| Q2 24 | $-65.8M | — | ||
| Q1 24 | $-52.1M | — |
| Q4 25 | -3370.0% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -958.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -520.7% | — |
| Q4 25 | 5.9% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 5.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 17.8% | — |
| Q4 25 | — | -0.35× | ||
| Q3 25 | — | 11.28× | ||
| Q2 25 | — | -17.24× | ||
| Q1 25 | — | -1.61× | ||
| Q4 24 | — | 12.13× | ||
| Q3 24 | — | 8.03× | ||
| Q2 24 | — | -0.34× | ||
| Q1 24 | — | 1.52× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
